These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 10694585)

  • 61. Safety of withholding anticoagulation in patients with mechanical prosthetic valves and intracranial haemorrhage.
    Krittalak K; Sawanyawisuth K; Tiamkao S
    Intern Med J; 2011 Oct; 41(10):750-4. PubMed ID: 22435901
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Quality of long-term oral anticoagulation: an observation study].
    Turk A; Sidler P; Bühler H; Christen S
    Praxis (Bern 1994); 2003 Oct; 92(42):1769-73. PubMed ID: 14598533
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Cardiac indications for oral anticoagulation].
    Roffi M; Oechslin E
    Praxis (Bern 1994); 2004 Sep; 93(38):1549-55. PubMed ID: 15495768
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy.
    Palareti G; Leali N; Coccheri S; Poggi M; Manotti C; D'Angelo A; Pengo V; Erba N; Moia M; Ciavarella N; Devoto G; Berrettini M; Musolesi S
    Lancet; 1996 Aug; 348(9025):423-8. PubMed ID: 8709780
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Capillary bleeding under oral anticoagulation.
    Leithäuser B; Mrowietz C; Hiebl B; Pindur G; Jung F
    Clin Hemorheol Microcirc; 2009; 43(1-2):167-71. PubMed ID: 19713611
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A method to determine the optimal intensity of oral anticoagulant therapy.
    Rosendaal FR; Cannegieter SC; van der Meer FJ; Briët E
    Thromb Haemost; 1993 Mar; 69(3):236-9. PubMed ID: 8470047
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Ambulatory follow-up in oral anticoagulation: recommendations for clinical practice].
    Christen Y; Perrier A; de Moerloose P
    Schweiz Med Wochenschr; 1996 Mar; 126(12):471-6. PubMed ID: 8650511
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Mechanical heart valve patients can manage oral anticoagulant therapy themselves.
    Christensen TD; Andersen NT; Attermann J; Hjortdal VE; Maegaard M; Hasenkam JM
    Eur J Cardiothorac Surg; 2003 Mar; 23(3):292-8. PubMed ID: 12614796
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Oral anticoagulation therapy in the primary care setting].
    Vinker S; Nakar S; Finkel S; Nir E; Hyam E
    Harefuah; 1997 Jun; 132(11):753-6, 824, 823. PubMed ID: 9223814
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Frequency of adverse events in patients with poor anticoagulation: a meta-analysis.
    Oake N; Fergusson DA; Forster AJ; van Walraven C
    CMAJ; 2007 May; 176(11):1589-94. PubMed ID: 17515585
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Hospitalized women experiencing an episode of excessive oral anticoagulation had a higher bleeding risk than men.
    Cosma Rochat M; Waeber G; Wasserfallen JB; Nakov K; Aujesky D
    J Womens Health (Larchmt); 2009 Mar; 18(3):321-6. PubMed ID: 19281315
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [The causes of intracranial hemorrhagic complications induced by antivitamins K].
    Lacroix P; Portefaix O; Boucher M; Ramiandrisoa H; Dumas M; Ravon R; Christides C; Laskar M
    Arch Mal Coeur Vaiss; 1994 Dec; 87(12):1715-9. PubMed ID: 7786112
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Improved therapeutic safety of oral anticoagulant therapy in Germany: the Saarland model.
    Mörsdorf S; Leipnitz G; Pindur G; Schenk JF; Erdlenbruch W; Krischek B; Wenzel E
    Semin Thromb Hemost; 1999; 25(1):49-55. PubMed ID: 10327221
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Pharmacoepidemiologic investigations about the interactions between oral anticoagulants and other drugs in patients with hemostasis disorders].
    Apostoae F; Tarţău L; Cimpoeşu D; Lupuşoru CE
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(4):1155-61. PubMed ID: 22276463
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Quality of oral anticoagulant control and treatment in Sweden. Duration of Anticoagulation (DURAC) Trial Study Group.
    Schulman S
    J Intern Med; 1994 Aug; 236(2):143-52. PubMed ID: 8046313
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Evidence that D-dimer levels predict subsequent thromboembolic and cardiovascular events in patients with atrial fibrillation during oral anticoagulant therapy.
    Sadanaga T; Sadanaga M; Ogawa S
    J Am Coll Cardiol; 2010 May; 55(20):2225-31. PubMed ID: 20466203
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Clinical experiences with anticoagulant long term treatment of predominantly cardiologic patients].
    Kubicek F; Praschl E
    Wien Klin Wochenschr; 1968 Nov; 80(44):813-9. PubMed ID: 4974107
    [No Abstract]   [Full Text] [Related]  

  • 78. [Is optimal anticoagulation possible in ambulatory practice? Report on a retrospective 5-year study of a cardiology practice].
    von Bertrab R
    Schweiz Med Wochenschr; 1985 Aug; 115(31-32):1092-105. PubMed ID: 4048907
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Morbidity and mortality in patients treated with oral anticoagulants].
    Navarro JL; Cesar JM; Fernández MA; Fontcuberta J; Reverter JC; Gol-Freixa J
    Rev Esp Cardiol; 2007 Dec; 60(12):1226-32. PubMed ID: 18082087
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Oral anticoagulation in surgical procedures: risks and recommendations.
    Torn M; Rosendaal FR
    Br J Haematol; 2003 Nov; 123(4):676-82. PubMed ID: 14616972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.